In AD, elevated β-N-acetylglucosaminidase (β-N-OGA) activity reduces protective O-GlcNAcylation of tau, facilitating its hyperphosphorylation and aggregation [20,59,68]. The gene discussed is MAPT; the disease is Alzheimer disease.